2007
DOI: 10.1016/j.jchromb.2007.04.014
|View full text |Cite
|
Sign up to set email alerts
|

In vivo pharmacokinetic and metabolism studies of ginsenoside Rd

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
41
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 80 publications
(44 citation statements)
references
References 17 publications
3
41
0
Order By: Relevance
“…No reports of ginsenosides glucuronidation were found in the literature. In a pharmacokinetic study in which ginsenoside Rd was administered intravenously to volunteers, no glucuronide conjugates were detected in plasma [76]. Another in vitro study on metabolism of ginsenoside Rg3 using rat S9 liver fraction did not detect any glucuronidated metabolites [77].…”
Section: Ginsengmentioning
confidence: 96%
“…No reports of ginsenosides glucuronidation were found in the literature. In a pharmacokinetic study in which ginsenoside Rd was administered intravenously to volunteers, no glucuronide conjugates were detected in plasma [76]. Another in vitro study on metabolism of ginsenoside Rg3 using rat S9 liver fraction did not detect any glucuronidated metabolites [77].…”
Section: Ginsengmentioning
confidence: 96%
“…Ginsenoside Rd (GSRd, Fig. 1) is one of the major active components of ginsenosides (Nah et al 2007;Yang et al 2007a).…”
Section: Introductionmentioning
confidence: 99%
“…10) However, several researchers reported that intact ginsenosides are only slightly absorbed through digestive tract, and the oral bioavailability of intact ginsenosides in the intestines is extremely low. [11][12][13][14] Ginsenosides act as precursors that are metabolized to the bioactive form by intestinal bacterial deglycosylation 15,16) and fatty acid esterification 17,18) in the body. Pharmacologic studies have shown the following metabolic pathways of ginsenosides in the human body: ginsenosides of the 20S-protopanaxadiol type are finally metabolized to 20S-protopanaxadiol 20-O-b-D-glucopyranoside (M 1 ), which is also called ginsenoside compound K; whereas ginsenosides of 20S-protopanaxatriol type are finally metabolized to 20S-protopanaxatriol (M 4 ) through cleavage of the oligosaccharides connected to the C-6 and C-20 hydroxyl groups of the aglycone by intestinal bacteria.…”
mentioning
confidence: 99%